Diet Matters in Breast Cancer Prognosis: Clinical Trial Evidence and Questions

Area of Science:

• Oncology
• Nutrition Science
• Clinical Trials

Background:

• Diet and weight are critical factors influencing breast cancer prognosis.
• Previous research suggests lifestyle interventions may impact cancer outcomes.
• The specific impact of a Mediterranean macrobiotic diet and weight loss on breast cancer recurrence requires further investigation.

Purpose of the Study:

• To evaluate the effect of a Mediterranean macrobiotic diet on 5-year breast cancer recurrence.
• To assess the association between adherence to the diet and breast cancer recurrence risk.
• To highlight the unknown effects of substantial weight loss on breast cancer prognosis.

Main Methods:

• The DIANA-5 randomized controlled trial involved participants with breast cancer.
• Intervention group followed a Mediterranean macrobiotic diet.
• Adherence to the diet was monitored, and breast cancer recurrence was tracked over 5 years.

Main Results:

• The Mediterranean macrobiotic diet showed no significant effect on 5-year breast cancer recurrence rates.
• High adherence to the diet was associated with a 41% lower risk of recurrence compared to controls.
• The study did not assess the impact of substantial weight loss on prognosis.

Conclusions:

• While the diet itself did not alter recurrence, high adherence suggests a potential protective role.
• Further research is needed to understand the interplay of diet adherence, weight management, and breast cancer outcomes.
• The DIANA-5 trial provides valuable insights into dietary strategies for breast cancer survivors.